Global Therapeutic Nuclear Medicines Market Growth 2020-2025

  • receipt Report ID : 226256
  • calendar_today Published On: Jan, 2020
  • file_copy Pages: 158
  • list Medical Devices

According to this study, over the next five years the Therapeutic Nuclear Medicines market will register a 18.7% CAGR in terms of revenue, the global market size will reach $ 2345.4 million by 2025, from $ 1182.5 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Therapeutic Nuclear Medicines business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Therapeutic Nuclear Medicines market by type, application, key manufacturers and key regions and countries.

This study considers the Therapeutic Nuclear Medicines value and volume generated from the sales of the following segments:

Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.

Radium-223

Lutetium-177

Iodine-131

Other

Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.

Thyroid

Bone Metastasis

Lymphoma

Other

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Spain

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.

Bayer

Progenics Pharmaceuticals

Novartis AG

Dongcheng

Q BioMed

China Isotope & Radiation

Lantheus

Curium Pharmaceuticals

Spectrum Pharmaceuticals

Jubilant DraxImage

International Isotopes

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives

To study and analyze the global Therapeutic Nuclear Medicines consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.

To understand the structure of Therapeutic Nuclear Medicines market by identifying its various subsegments.

Focuses on the key global Therapeutic Nuclear Medicines manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.

To analyze the Therapeutic Nuclear Medicines with respect to individual growth trends, future prospects, and their contribution to the total market.

To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

To project the consumption of Therapeutic Nuclear Medicines submarkets, with respect to key regions (along with their respective key countries).

To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

To strategically profile the key players and comprehensively analyze their growth strategies.

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

Table of Contents

1 Scope of the Report

1.1 Market Introduction

1.2 Research Objectives

1.3 Years Considered

1.4 Market Research Methodology

1.5 Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Therapeutic Nuclear Medicines Consumption 2015-2025

2.1.2 Therapeutic Nuclear Medicines Consumption CAGR by Region

2.2 Therapeutic Nuclear Medicines Segment by Type

2.2.1 Radium-223

2.2.2 Lutetium-177

2.2.3 Iodine-131

2.2.4 Other

2.3 Therapeutic Nuclear Medicines Consumption by Type

2.3.1 Global Therapeutic Nuclear Medicines Consumption Market Share by Type (2015-2020)

2.3.2 Global Therapeutic Nuclear Medicines Revenue and Market Share by Type (2015-2020)

2.3.3 Global Therapeutic Nuclear Medicines Sale Price by Type (2015-2020)

2.4 Therapeutic Nuclear Medicines Segment by Application

2.4.1 Thyroid

2.4.2 Bone Metastasis

2.4.3 Lymphoma

2.4.4 Other

2.5 Therapeutic Nuclear Medicines Consumption by Application

2.5.1 Global Therapeutic Nuclear Medicines Consumption Market Share by Type (2015-2020)

2.5.2 Global Therapeutic Nuclear Medicines Value and Market Share by Type (2015-2020)

2.5.3 Global Therapeutic Nuclear Medicines Sale Price by Type (2015-2020)

3 Global Therapeutic Nuclear Medicines by Company

3.1 Global Therapeutic Nuclear Medicines Sales Market Share by Company

3.1.1 Global Therapeutic Nuclear Medicines Sales by Company (2018-2020)

3.1.2 Global Therapeutic Nuclear Medicines Sales Market Share by Company (2018-2020)

3.2 Global Therapeutic Nuclear Medicines Revenue Market Share by Company

3.2.1 Global Therapeutic Nuclear Medicines Revenue by Company (2018-2020)

3.2.2 Global Therapeutic Nuclear Medicines Revenue Market Share by Company (2018-2020)

3.3 Global Therapeutic Nuclear Medicines Sale Price by Company

3.4 Global Therapeutic Nuclear Medicines Manufacturing Base Distribution, Sales Area, Type by Company

3.4.1 Global Therapeutic Nuclear Medicines Manufacturing Base Distribution and Sales Area by Company

3.4.2 Players Therapeutic Nuclear Medicines Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 Therapeutic Nuclear Medicines by Regions

4.1 Therapeutic Nuclear Medicines by Regions

4.2 Americas Therapeutic Nuclear Medicines Consumption Growth

4.3 APAC Therapeutic Nuclear Medicines Consumption Growth

4.4 Europe Therapeutic Nuclear Medicines Consumption Growth

4.5 Middle East & Africa Therapeutic Nuclear Medicines Consumption Growth

5 Americas

5.1 Americas Therapeutic Nuclear Medicines Consumption by Countries

5.1.1 Americas Therapeutic Nuclear Medicines Consumption by Countries (2015-2020)

5.1.2 Americas Therapeutic Nuclear Medicines Value by Countries (2015-2020)

5.2 Americas Therapeutic Nuclear Medicines Consumption by Type

5.3 Americas Therapeutic Nuclear Medicines Consumption by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

5.8 Key Economic Indicators of Few Americas Countries

6 APAC

6.1 APAC Therapeutic Nuclear Medicines Consumption by Regions

6.1.1 APAC Therapeutic Nuclear Medicines Consumption by Regions (2015-2020)

6.1.2 APAC Therapeutic Nuclear Medicines Value by Regions (2015-2020)

6.2 APAC Therapeutic Nuclear Medicines Consumption by Type

6.3 APAC Therapeutic Nuclear Medicines Consumption by Application

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 Key Economic Indicators of Few APAC Regions

7 Europe

7.1 Europe Therapeutic Nuclear Medicines by Countries

7.1.1 Europe Therapeutic Nuclear Medicines Consumption by Countries (2015-2020)

7.1.2 Europe Therapeutic Nuclear Medicines Value by Countries (2015-2020)

7.2 Europe Therapeutic Nuclear Medicines Consumption by Type

7.3 Europe Therapeutic Nuclear Medicines Consumption by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

7.9 Spain

7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa

8.1 Middle East & Africa Therapeutic Nuclear Medicines by Countries

8.1.1 Middle East & Africa Therapeutic Nuclear Medicines Consumption by Countries (2015-2020)

8.1.2 Middle East & Africa Therapeutic Nuclear Medicines Value by Countries (2015-2020)

8.2 Middle East & Africa Therapeutic Nuclear Medicines Consumption by Type

8.3 Middle East & Africa Therapeutic Nuclear Medicines Consumption by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers and Impact

9.1.1 Growing Demand from Key Regions

9.1.2 Growing Demand from Key Applications and Potential Industries

9.2 Market Challenges and Impact

9.3 Market Trends

10 Marketing, Distributors and Customer

10.1 Sales Channel

10.1.1 Direct Channels

10.1.2 Indirect Channels

10.2 Therapeutic Nuclear Medicines Distributors

10.3 Therapeutic Nuclear Medicines Customer

11 Global Therapeutic Nuclear Medicines Market Forecast

11.1 Global Therapeutic Nuclear Medicines Consumption Forecast (2021-2025)

11.2 Global Therapeutic Nuclear Medicines Forecast by Regions

11.2.1 Global Therapeutic Nuclear Medicines Forecast by Regions (2021-2025)

11.2.2 Global Therapeutic Nuclear Medicines Value Forecast by Regions (2021-2025)

11.2.3 Americas Consumption Forecast

11.2.4 APAC Consumption Forecast

11.2.5 Europe Consumption Forecast

11.2.6 Middle East & Africa Consumption Forecast

11.3 Americas Forecast by Countries

11.3.1 United States Market Forecast

11.3.2 Canada Market Forecast

11.3.3 Mexico Market Forecast

11.3.4 Brazil Market Forecast

11.4 APAC Forecast by Countries

11.4.1 China Market Forecast

11.4.2 Japan Market Forecast

11.4.3 Korea Market Forecast

11.4.4 Southeast Asia Market Forecast

11.4.5 India Market Forecast

11.4.6 Australia Market Forecast

11.5 Europe Forecast by Countries

11.5.1 Germany Market Forecast

11.5.2 France Market Forecast

11.5.3 UK Market Forecast

11.5.4 Italy Market Forecast

11.5.5 Russia Market Forecast

11.5.6 Spain Market Forecast

11.6 Middle East & Africa Forecast by Countries

11.6.1 Egypt Market Forecast

11.6.2 South Africa Market Forecast

11.6.3 Israel Market Forecast

11.6.4 Turkey Market Forecast

11.6.5 GCC Countries Market Forecast

11.7 Global Therapeutic Nuclear Medicines Forecast by Type

11.8 Global Therapeutic Nuclear Medicines Forecast by Application

12 Key Players Analysis

12.1 Bayer

12.1.1 Company Information

12.1.2 Therapeutic Nuclear Medicines Product Offered

12.1.3 Bayer Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2018-2020)

12.1.4 Main Business Overview

12.1.5 Bayer Latest Developments

12.2 Progenics Pharmaceuticals

12.2.1 Company Information

12.2.2 Therapeutic Nuclear Medicines Product Offered

12.2.3 Progenics Pharmaceuticals Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2018-2020)

12.2.4 Main Business Overview

12.2.5 Progenics Pharmaceuticals Latest Developments

12.3 Novartis AG

12.3.1 Company Information

12.3.2 Therapeutic Nuclear Medicines Product Offered

12.3.3 Novartis AG Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2018-2020)

12.3.4 Main Business Overview

12.3.5 Novartis AG Latest Developments

12.4 Dongcheng

12.4.1 Company Information

12.4.2 Therapeutic Nuclear Medicines Product Offered

12.4.3 Dongcheng Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2018-2020)

12.4.4 Main Business Overview

12.4.5 Dongcheng Latest Developments

12.5 Q BioMed

12.5.1 Company Information

12.5.2 Therapeutic Nuclear Medicines Product Offered

12.5.3 Q BioMed Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2018-2020)

12.5.4 Main Business Overview

12.5.5 Q BioMed Latest Developments

12.6 China Isotope & Radiation

12.6.1 Company Information

12.6.2 Therapeutic Nuclear Medicines Product Offered

12.6.3 China Isotope & Radiation Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2018-2020)

12.6.4 Main Business Overview

12.6.5 China Isotope & Radiation Latest Developments

12.7 Lantheus

12.7.1 Company Information

12.7.2 Therapeutic Nuclear Medicines Product Offered

12.7.3 Lantheus Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2018-2020)

12.7.4 Main Business Overview

12.7.5 Lantheus Latest Developments

12.8 Curium Pharmaceuticals

12.8.1 Company Information

12.8.2 Therapeutic Nuclear Medicines Product Offered

12.8.3 Curium Pharmaceuticals Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2018-2020)

12.8.4 Main Business Overview

12.8.5 Curium Pharmaceuticals Latest Developments

12.9 Spectrum Pharmaceuticals

12.9.1 Company Information

12.9.2 Therapeutic Nuclear Medicines Product Offered

12.9.3 Spectrum Pharmaceuticals Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2018-2020)

12.9.4 Main Business Overview

12.9.5 Spectrum Pharmaceuticals Latest Developments

12.10 Jubilant DraxImage

12.10.1 Company Information

12.10.2 Therapeutic Nuclear Medicines Product Offered

12.10.3 Jubilant DraxImage Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2018-2020)

12.10.4 Main Business Overview

12.10.5 Jubilant DraxImage Latest Developments

12.11 International Isotopes

12.11.1 Company Information

12.11.2 Therapeutic Nuclear Medicines Product Offered

12.11.3 International Isotopes Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2018-2020)

12.11.4 Main Business Overview

12.11.5 International Isotopes Latest Developments

13 Research Findings and Conclusion

List of Tables

Table 1. Research Methodology

Table 2. Data Source

Table 3. Therapeutic Nuclear Medicines Consumption CAGR by Region 2015-2025 ($ Millions)

Table 4. Major

Please fill the form below, to recieve the report sample


+1